1. Antibodies
  2. Homo sapiens
  3. DGCR8

ENCAB462ILE

Antibody against Homo sapiens DGCR8

Homo sapiens
K562, HepG2
characterized to standards
Homo sapiens
adrenal gland
characterized to standards with exemption
Homo sapiens
any cell type or tissue
partially characterized
Status
released
Source (vendor)
Bethyl Labs
Product ID
A302-468A
Lot ID
1
Characterized targets
DGCR8 (Homo sapiens)
Host
rabbit
Clonality
polyclonal
Purification
affinity
Isotype
IgG
External resources

Characterizations

DGCR8 (Homo sapiens)
adrenal gland
Method: immunoprecipitation
Attachment from submitter
Attachment from submitters
exempt from standards
Caption
IP-Western Blot analysis of human adrenal gland lysate using DGCR8 specific antibody. Lane 1 is 1% of 10 million tissue lysate input and lane 2 is 10% of IP enrichment using rabbit polyclonal anti-DGCR8 antibody (lanes under 'DGCR8')). Lanes 3 and 4 indicate a technical replicate of lanes 1 and 2.
Submitter comment
There was not enough adrenal tissue to full characterize this antibody in this specific tissue type.
Reviewer comment
As this tissue was part of the GTex samples, there was not enough adrenal tissue to fully characterize this antibody lot in this specific tissue type. However, there is now a good WB for this antibody lot in adrenal gland tissue, as well as compliant primaries multiple cell lines. Therefore, this primary characterization is compliant via exemption from standards.
Submitted by
Steven Blue
Lab
Gene Yeo, UCSD
DGCR8 (Homo sapiens)
Method: immunoprecipitation
Attachment from submitter
Attachment from submitters
not submitted for review by lab
Caption
IP-WB characterization of DGCR8 specific antibody in K562 cell line . Lane 1 is 2.5% of five million K562 whole cell lysate Input, lane 2 is 2.5% of supernatant after immunoprecipitation and Lane 3 is 50% of IP enrichment using rabbit polyclonal anti-DGCR8 Antibody. This antibody passes preliminary validation and will be further pursued for primary and secondary validation.
Submitted by
Balaji Sundararaman
Lab
Gene Yeo, UCSD
DGCR8 (Homo sapiens)
Method: knockdown or knockout
Attachment from submitter
Attachment from submitters
compliant
Caption
Western blot following CRISPR against DGCR8 in K562 whole cell lysate using DGCR8 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against DGCR8. DGCR8 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow. This western blot was done 22 days after the CRISPR experiment process.
Submitted by
Xintao Wei
Lab
Brenton Graveley, UConn
DGCR8 (Homo sapiens)
Method: knockdown or knockout
Attachment from submitter
Attachment from submitters
compliant
Caption
Western blot following CRISPR against DGCR8 in K562 whole cell lysate using DGCR8 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against DGCR8. DGCR8 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow. This western blot was done 30 days after the CRISPR experiment process.
Submitted by
Xintao Wei
Lab
Brenton Graveley, UConn
DGCR8 (Homo sapiens)
Method: knockdown or knockout
Attachment from submitter
Attachment from submitters
compliant
Caption
Western blot following CRISPR against DGCR8 in K562 whole cell lysate using DGCR8 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against DGCR8. DGCR8 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow. This western blot was done 41 days after the CRISPR experiment process.
Submitted by
Xintao Wei
Lab
Brenton Graveley, UConn
DGCR8 (Homo sapiens)
HepG2
Method: immunoprecipitation
Attachment from submitter
Attachment from submitters
compliant
Caption
IP-Western Blot analysis of HepG2 whole cell lysate using DGCR8 specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-DGCR8 antibody (lanes under 'DGCR8').
Submitted by
Steven Blue
Lab
Gene Yeo, UCSD
DGCR8 (Homo sapiens)
K562
Method: immunoprecipitation
Attachment from submitter
Attachment from submitters
compliant
Caption
IP-Western Blot analysis of K562 whole cell lysate using DGCR8 specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-DGCR8 antibody (lanes under 'DGCR8').
Submitted by
Steven Blue
Lab
Gene Yeo, UCSD